0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 1-12 of 12 Articles
Original Investigation | 
Yaron Finkelstein, MD, ABCP(Dip); Erin M. Macdonald, MSc; Simon Hollands, MSc; et al.
JAMA Psychiatry. 2015;72(6):570-575. doi:10.1001/jamapsychiatry.2014.3188.
Includes: Supplemental Content

Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Nestor D. Kapusta, MD; Jeffrey H. Coben, MD
JAMA Psychiatry. 2014;71(3):231-232. doi:10.1001/jamapsychiatry.2013.3738.

From the JAMA Network | 
Joseph T. Coyle, MD
JAMA Psychiatry. 2013;70(10):1113-1114. doi:10.1001/jamapsychiatry.2013.1949.

Original Article |  FREE
Christina R. Di Iorio, EdM; Tristan J. Watkins, BA; Mary S. Dietrich, PhD; et al.
Arch Gen Psychiatry. 2012;69(4):399-409. doi:10.1001/archgenpsychiatry.2011.156.

Original Article |  FREE
Maryse F. Bouchard, PhD, MSc; David C. Bellinger, PhD, MSc; Jennifer Weuve, MPH, ScD; et al.
Arch Gen Psychiatry. 2009;66(12):1313-1319. doi:10.1001/archgenpsychiatry.2009.164.

Original Article |  FREE
Hanh T. T. Ngo, BSc(Hons); Robert J. Tait, PhD; Gary K. Hulse, PhD
Arch Gen Psychiatry. 2008;65(4):457-465. doi:10.1001/archpsyc.65.4.457.

Original Article |  FREE
Carol L. M. Caton, PhD; Robert E. Drake, MD, PhD; Deborah S. Hasin, PhD; et al.
Arch Gen Psychiatry. 2005;62(2):137-145. doi:10.1001/archpsyc.62.2.137.

Perspectives | 
Daniel R. Weinberger, MD; Robert K. McClure, MD
Arch Gen Psychiatry. 2002;59(6):553-558. doi:10.1001/archpsyc.59.6.553.

Commentary | 
Una D. McCann, MD; George A. Ricaurte, MD, PhD; Mark E. Molliver, MD
Arch Gen Psychiatry. 2001;58(10):907-908. doi:10.1001/archpsyc.58.10.907.

Commentary | 
Andrew L. Stoll, MD; Lauren B. Marangell, MD
Arch Gen Psychiatry. 1999;56(5):415-416. doi:10.1001/archpsyc.56.5.415.

Commentary | 
Donald F. Klein, MD
Arch Gen Psychiatry. 1999;56(4):353-354. doi:10.1001/archpsyc.56.4.353.

Original Article |  FREE
Emil F. Coccaro, MD; Richard J. Kavoussi, MD; Richard L. Hauger, MD; et al.
Arch Gen Psychiatry. 1998;55(8):708-714. doi:10.1001/archpsyc.55.8.708.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.
JAMA
Medical News & Perspectives  | 
Margaret A. Hamburg, MD, Reflects on 6 Years at FDA
Rita Rubin, MA